Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Oligodendroglioma and MGMT[original query] |
---|
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors. Journal of neuro-oncology 2011 Nov 105 (2): 345-57. Mellai Marta, Piazzi Angela, Caldera Valentina, Monzeglio Oriana, Cassoni Paola, Valente Guido, Schiffer Davi |
Molecular markers in low-grade gliomas: predictive or prognostic? Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age. Journal of neuro-oncology 2013 May 112 (3): 439-48. Ha Sang Yun, Kang So Young, Do In-Gu, Suh Yeon-L |
Impact of MTHFR polymorphisms on methylation of MGMT in glioma patients from Northeast China with different folate levels. Genetics and molecular research : GMR 2013 12 (4): 5160-71. Liu N, Jiang J, Song Y J, Zhao S G, Tong Z G, Song H S, Wu H, Zhu J Y, Gu Y H, Sun Y, Hua W, Qi J |
Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients. World journal of surgical oncology 2013 11 (1): 284. Takahashi Yoshinobu, Nakamura Hideo, Makino Keishi, Hide Takuichiro, Muta Daisuke, Kamada Hajime, Kuratsu Jun-Ic |
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene. Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas. Chinese medical journal 2019 Dec . Wang Lei-Ming, Li Zhuo, Piao Yue-Shan, Cai Yan-Ning, Zhang Li-Yan, Ge Hai-Jing, Xu Wei-Wei, Lu De-Ho |
Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II. Scientific reports 2020 11 10 (1): 19758. Karschnia Philipp, Teske Nico, Dorostkar Mario M, Siller Sebastian, Weller Jonathan, Baehring Joachim M, Dietrich Jorg, von Baumgarten Louisa, Herms Jochen, Tonn Joerg-Christian, Thon Nikl |
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: